Late effects of treatment for early-stage Hodgkin's disease - PubMed (original) (raw)

Late effects of treatment for early-stage Hodgkin's disease

J D Brierley et al. Br J Cancer. 1998 Apr.

Free PMC article

Abstract

A comprehensive survey of late effects (physical, social and reproductive) following treatment at a single institution for early stage Hodgkin's disease (HD) was performed. A total of 611 patients with stage I and II HD treated between 1973 and 1984 were reviewed; 460 were alive and were mailed a self-reported questionnaire. A total of 363 (79%) replies were received. Twenty patients died of second malignancy, 14 of heart disease and nine from respiratory disease. There were 37 cases of second malignancy [relative risk (RR) 2.2, absolute excess risk (AR) 35.8]. The 15-year incidence of heart disease was 11% and there were nine myocardial infarction deaths (RR 1.55, AR 5.4). Twenty-eight (8%) respondents stated that their career had been greatly interfered with, 53 (14.5%) perceived financial loss. Sexual activity was disrupted in 25.8%. In total, 56 men had fathered 112 pregnancies. Of 171 women, 40.3% became pregnant, resulting in 92 live births. A total of 43 men and 16 women had sought medical advice with regard to infertility.

PubMed Disclaimer

Similar articles

• [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
  Morales MD, González FA, Villegas A, del Potro E, Díaz Mediavilla J, Martínez R, Alvarez A, Colomé JA. Morales MD, et al. Sangre (Barc). 1992 Dec;37(6):429-33. Sangre (Barc). 1992. PMID: 1293793 Spanish.
• Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
  Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN. Mauch PM, et al. Cancer J Sci Am. 1995 May-Jun;1(1):33-42. Cancer J Sci Am. 1995. PMID: 9166452
• Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
  Hancock SL, Tucker MA, Hoppe RT. Hancock SL, et al. JAMA. 1993 Oct 27;270(16):1949-55. JAMA. 1993. PMID: 8411552
• [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
  Streit M, Thiel E, Kreuser ED. Streit M, et al. Dtsch Med Wochenschr. 1995 Aug 4;120(31-32):1093-9. doi: 10.1055/s-2008-1055450. Dtsch Med Wochenschr. 1995. PMID: 7641593 Review. German. No abstract available.
• The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
  Donaldson SS, Hancock SL, Hoppe RT. Donaldson SS, et al. Cancer J Sci Am. 1999 Nov-Dec;5(6):325-33. Cancer J Sci Am. 1999. PMID: 10606471 Review.

Cited by

• Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
  Juul SJ, Rossetti S, Kicinski M, van der Kaaij MAE, Giusti F, Meijnders P, Aleman BMP, Raemaekers JMM, Kluin-Nelemans HC, Spina M, Fermé C, Renaud L, Casasnovas O, Stamatoullas A, André M, Le Bras F, Plattel WJ, Henry-Amar M, Hutchings M, Maraldo MV. Juul SJ, et al. J Cancer Surviv. 2024 Jun;18(3):727-738. doi: 10.1007/s11764-022-01305-w. Epub 2022 Nov 28. J Cancer Surviv. 2024. PMID: 36441393
• Maternal and perinatal outcomes following a diagnosis of Hodgkin lymphoma during or prior to pregnancy: A systematic review.
  Houlihan OA, Buckley D, Maher GM, McCarthy FP, Khashan AS. Houlihan OA, et al. BJOG. 2023 Mar;130(4):336-347. doi: 10.1111/1471-0528.17347. Epub 2022 Dec 12. BJOG. 2023. PMID: 36424902 Free PMC article. Review.
• Attitudes toward fertility and fertility preservation in women with glioma.
  Stiner RK, Clarke JL, Sinha N, Chan J, Letourneau JM, Niemasik EE, Rabbitt JE, Chang SM, Butowski NA, Prados MD, Rosen MP. Stiner RK, et al. Neurooncol Pract. 2019 May;6(3):218-225. doi: 10.1093/nop/npy036. Epub 2018 Sep 26. Neurooncol Pract. 2019. PMID: 31386027 Free PMC article.
• Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.
  Boyne DJ, Mickle AT, Brenner DR, Friedenreich CM, Cheung WY, Tang KL, Wilson TA, Lorenzetti DL, James MT, Ronksley PE, Rabi DM. Boyne DJ, et al. Cancer Med. 2018 Sep;7(9):4801-4813. doi: 10.1002/cam4.1572. Epub 2018 Aug 15. Cancer Med. 2018. PMID: 30112841 Free PMC article.
• Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
  Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang ET, Neovius M, Smedby KE. Glimelius I, et al. J Cancer Surviv. 2015 Dec;9(4):599-609. doi: 10.1007/s11764-015-0436-0. Epub 2015 Feb 18. J Cancer Surviv. 2015. PMID: 25689964

References

1. 1. Cancer J Sci Am. 1995 May-Jun;1(1):33-42 - PubMed
2. 1. N Engl J Med. 1996 Mar 21;334(12):745-51 - PubMed
3. 1. JAMA. 1981 Apr 3;245(13):1323-8 - PubMed
4. 1. Semin Oncol. 1990 Dec;17(6):704-15 - PubMed
5. 1. Cancer. 1985 Aug 1;56(3):642-8 - PubMed

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program